Skip to content

Huaier Granule for Prevention of Recurrence and Metastasis of stage I and IIIa NSCLC after postoperative adjuvant chemotherapy:a multicenter real world study

Huaier Granule for Prevention of Recurrence and Metastasis of stage I and IIIa NSCLC after postoperative adjuvant chemotherapy:a multicenter real world study

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016270
Enrollment
Unknown
Registered
2018-05-24
Start date
2018-06-01
Completion date
Unknown
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small Cell Lung Cancer

Interventions

Sponsors

First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with complete resection who are at TNM (primary tumor, regional nodes, metastasis) stage I-IIIa; 2. postoperative pathology confirmed for non-small cell lung cancer; 3. Patients over 18 years old, no gender restriction; 4. Before the start of the study, patient fully understands the study and is willing to sign the informed consent form;

Exclusion criteria

Exclusion criteria: 1. Receiving adjunvant chemotherapy patients started greater than 24 weeks from surgical resection; 2. There is no clear pathological diagnosis; 3. Highly suspected or confirmed recurrence of metastases; 4. Combined with other cancer; 5. Conditions that are considered not suitable for this study investigators.

Design outcomes

Primary

MeasureTime frame
disease-free survival;

Secondary

MeasureTime frame
overall survivals;Quality of Life;tumor markers;Immunological indexes;

Countries

China

Contacts

Public ContactSun Guoping

First Affiliated Hospital of Anhui Medical University

sunguoping@ahmu.edu.cn+86 13805609309

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026